Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and for weight management in adults with obesity or overweight with weight-related comorbidities
GLP-1 (glucagon-like peptide-1) is an incretin hormone released by the intestines after eating
Aim for the boring but effective stuff: consistent bedtime, consistent wake time, and screens out of your face before bed
The goal isnt to eat less at all costs
In 12 months old mice, dAla(2)GIP was given once daily for 21 days
US$ 21.44
US$ 20.57
US$ 29.75
US$ 29.94
US$ 25.12
US$ 27.10
US$ 22.99
US$ 23.29
US$ 21.10
US$ 24.35
US$ 26.30
